A new study from the University of Bath has found that for older adults with atrial fibrillation (AF), stopping blood ...

Two Phase III trials found that apixaban was more effective for stroke prevention than either aspirin or warfarin in patients with atrial fibrillation (AF), with a similar (versus aspirin ...

Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen ...

Further trials comparing aspirin with newer anticoagulants (dabigatran, apixaban and rivaroxaban) are necessary to assess the role of each agent in stroke prevention in patients with AF.

The OCEANIC-AF is comparing asundexian to Pfizer and Bristol-Myers Squibb’s widely-used oral Factor Xa inhibitor Eliquis (apixaban) in AF patients at risk of a stroke, to see how well they ...

Eliquis brought in almost $6 billion, up 21% thanks to rising use for non-valvular atrial fibrillation (AF), while sales of Vyndaqel/Vyndamax rose 56% to top $2 billion for the first time on ...

The following is a summary of “Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: ...

Cai et al. report gate-injection-mode floating-gate memories based on MoS2 channel. The coplanar device design and bi-pulse state programming enable 8-bit conductance states at 3 V. Image ...

The Heart and Vascular Institute of Eastern Kentucky at Pikeville Medical Center announced in a statement it reached a milestone March 5 as it performed its 100th Hybrid AF Therapy ...